🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Evaluate the proportion of patients with an urticaria control test \[UCT\] ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2015-04-22
Trial ID
NCT02550106
Treatments Being Tested
This study will assess the efficacy, safety and tolerability of omalizumab,...
Status
Completed
Location
Novartis Investigative Site
Start Date
2010-09
Trial ID
NCT01202903
Treatments Being Tested
Aim: The aim of this study was to investigate the effect of subcutaneous in...
Status
Completed
Location
University of Health Sciences
Start Date
2018-06-05
Trial ID
NCT04210323
Treatments Being Tested
A single dose, double blind comparative trial to assess the pharmacokinetic...
Status
Completed
Location
Q-Pharm Pty Ltd
Start Date
2022-02-16
Trial ID
NCT05053334
Treatments Being Tested
To demonstrate the efficacy and safety of Omalizumab in a new indication, t...
Status
Completed
Location
Departamento de Alergología. Clínica Universidad de Navarra
Start Date
2014-01
Trial ID
NCT02012387
Treatments Being Tested
This study aims to evaluate the safety, tolerability, pharmacokinetics (PK)...
Status
Completed
Location
Hallym University Sacred Heart Hospital
Start Date
2023-08-23
Trial ID
NCT05960708
Treatments Being Tested
Chronic urticaria can be defined as the occurrence of widespread daily or a...
Status
Completed
Location
Hospital Santiago Apostol
Start Date
2012-03
Trial ID
NCT01713725
Treatments Being Tested
This is a single center, non-comparative exploratory study, to investigate ...
Status
Completed
Location
ASTHMA Inc Clinical Research Center
Start Date
2016-09
Trial ID
NCT02814630
Treatments Being Tested
This study enrolled 30 healthy volunteers and 30 patients with atopic asthm...
Status
Completed
Location
Multiple Locations
Start Date
2008-08
Trial ID
NCT00777764
Food allergy affects up to 4% of the U.S. population and is most common in ...
Status
Completed
Location
Stanford University School of Medicine
Start Date
2010-08
Trial ID
NCT01157117
Treatments Being Tested